The 2 Minute Medicine® Podcast

We begin this episode by discussing our article of the week from from the New England Journal of Medicine, entitled “Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.” In the second half, we have a conversation about Alzheimer's disease and how a drug called Donanemab has shown a 29% slower rate of decline and cognitive function. Next, we look at complications of bariatric surgery, the medical effects of heat exhaustion and what we can do to prevent it, and conclude with a conversation about energy drinks and it's lesser known side effects.

We begin this episode by discussing our article of the week from JAMA and is entitled, “Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021. In the second half of our episode, we begin by discussing the FIFA Women's World Cup and some of the strides taken to protect and support female athletes. Then we discuss National Immunization Awareness Month and some health tips for heading back-to-school. Finally, we conclude with a discussion on Overdose Awareness Day and the importance of naloxone in preventing deaths due to overdose.

We begin this episode by discussing our article of the week from BMC medicine, “Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial”. In the second half of our episode, we begin with a discussion about a blood test that was recently approved by the federal drug administration that can detect those at a greater risk for pre-eclampsia. Then we discuss the American Medical Association's new policy regarding the use of BMI in medical practice. Finally, we end with a conversation about Madonna's recent sepsis scare, as well as some of the injuries seen in the latest edition of the Tour de France.

We begin this episode by discussing our article of the week from the New England Journal of Medicine entitled “Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.”In the second half of our episode, we begin with a discussion about how the Supreme Court of the United States may impact college admissions for the foreseeable future. Then we explore the latest information regarding the link between a beloved artificial sweetener, and cancer. Last, but not least, we have a conversation about blood clots along with the stars who have experienced them, and psychedelics, a class of drugs recently approved for mental health treatment in Australia!

We begin this episode by discussing our article of the week from the New England Journal of Medicine entitled “Hydrocortisone in severe community-acquired pneumonia.“. In the second half of our episode, we bring a medical eye to popular events. We begin with a discussion about how the federal drug administration recently approved a drug to treat some symptoms of menopause. Then we take a closer look at the affordable care act mandate for preventative care. Last, but not least, we have a conversation about pride month and inequalities that exist in the healthcare system for the LGBTQ+ community and Nirsevimab, an antibody that can help prevent severe symptoms of RSV in infants!

We begin this episode by discussing our article of the week comes from the New England Journal of Medicine and is entitled “Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy“. In the second half of our episode, we bring a medical eye to popular events. We begin a discussion about antibiotic resistance, and how a team from McMaster University decided to leverage a powerful tool in their arsenal of antibiotic discovery, artificial intelligence. Next, we discuss how Melissa Gilbert, known for her role in “Little House on the Prairie”, experienced a bug bite that led to an emergency room visit and overnight hospitalization. We conclude by taking a closer look at why Canada is printing health warnings on individual cigarettes and a conversation about the importance of CPR. 

Welcome to the 2 Minute Medicine® Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. For the full transcript of this episode and more, please visit our website at https://www.2minutemedicine.com/the-2-minute-medicine-podcast-episode-15/ We begin this episode by discussing our article of the week which comes from  Our article of the week comes from The Lancet and is entitled “Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.” (01:24) First article of the week.  In the second half of our episode, we bring a medical eye to popular events. First, we take a closer look at how the FDA has recommended making a hormonal contraceptive pill, Opill, available over the counter. We then have a conversation about the recent pancreatic cancer vaccine trial, delving deeper into the subject of cancer immunotherapy. We conclude with a conversation about how Montana has become the first state to fully ban TikTok. We discuss the implications of social media on mental health, specifically among teenagers. (04:00) OTC Birth Control (06:51) Pancreatic Cancer Vaccine (08:53) Montana's ban on TikTok Please head to our website at 2minutemedicine.com to learn more and to access all of our content including medical study summaries, visual abstracts, excerpts from our Classics book series which is available on Amazon, and The Scan, which is our medical newsletter. To make sure that you don’t miss any of our content please subscribe and follow us on Twitter or Instagram @2minmed!

Welcome to the 2 Minute Medicine® Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. For the full transcript of this episode and more, please visit our website at https://www.2minutemedicine.com/the-2-minute-medicine-podcast-episode-15/ We begin this episode by discussing our article of the week which comes from the New England Journal of Medicine and is entitled  “Long-Term Health Consequences After Ovarian Removal at Benign Hysterectomy: A Nationwide Cohort Study.” (00:00) Introduction.  (01:24) First article of the week.  In the second half of our episode, we bring a medical eye to popular events. First, we take a closer look at how the recommendations around breast cancer screening are changing as a result of emerging evidence on breast cancer risk in young people. Next, we discuss what the end of COVID-19's emergency status means, the impact of Canadian Wildfires on the health of nearby residents and in honor of National Nurses Week May 6-12, we celebrate the important work that nurses do and draw attention to the current nursing shortage. (03:59) Mammograms (07:06) COVID-19 (08:30) The impact of wildfires on health (09:50) National Nurses Week Please head to our website at 2minutemedicine.com to learn more and to access all of our content including medical study summaries, visual abstracts, excerpts from our Classics book series which is available on Amazon, and The Scan, which is our medical newsletter. To make sure that you don’t miss any of our content please subscribe and follow us on Twitter or Instagram @2minmed!

Welcome to the 2 Minute Medicine® Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. We begin this episode by discussing our article of the week which comes from the New England Journal of Medicine and is entitled “Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.” (00:00) Introduction.  (01:22) First article of the week.  In the second half of our episode, we bring a medical eye to popular events. In this episode, we take a closer look at how Xylazine, a drug initially intended for veterinary use, is making its way into recreational drugs across America and Canada. We also discuss the recent FDA approval of Narcan for over-the-counter use, a $462 million dollar 'vape usage crisis' lawsuit, and how Ghana became the first country in the world to approve a new Malaria vaccine, the R21 Matrix-M vaccine. (04:04) Xylazine (06:11) FDA approval of Narcan for over-the-counter use (08:20) Vape usage crisis (10:42) New Malaria vaccine Please head to our website at 2minutemedicine.com to learn more and to access all of our content including medical study summaries, visual abstracts, excerpts from our Classics book series which is available on Amazon, and The Scan, which is our medical newsletter. To make sure that you don’t miss any of our content please subscribe and follow us on Twitter or Instagram @2minmed!

Welcome to the 2 Minute Medicine® Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. We begin this episode by discussing our two articles of the week. Our first article of the week comes from the New England Journal of Medicine and is entitled “Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.” Our second article of the week comes from the New England Journal of Medicine and is entitled “Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.” (00:00) Introduction.  (01:25) First article of the week.  (04:10) Second article of the week.  In the second half of our episode, we bring a medical eye to popular events. In this episode, we take a closer look at how around 15 million Americans could lose their Medicaid coverage, discuss aerospace medicine, Hugh Jackman’s skin cancer scare, earth day, and more! (06:52) The scan “Millions off medicaid” (09:28) Aerospace medicine.  (11:28) Hugh Jackman and skin cancer (13:04) Earth day.  Please head to our website at 2minutemedicine.com to learn more and to access all of our content including medical study summaries, visual abstracts, excerpts from our Classics book series which is available on Amazon, and The Scan, which is our medical newsletter. To make sure that you don’t miss any of our content please subscribe and follow us on Twitter or Instagram @2minmed!